-
Major currency pairs are trading in narrow ranges today. The Japanese market remains closed due to a holiday.
-
Weekend reports indicate that Washington is encouraging Kyiv to accept concessions to Russia as part of a modified peace proposal. Territorial and security issues remain unresolved.
-
Brent/WTI slipped slightly at the start of the new week on speculation that a Russia–Ukraine deal could unlock sanctions. The declines have now been fully erased.
-
Chinese semiconductor stocks fell on rumors that Trump may allow sales of Nvidia’s H200 chips to China.
-
The market expects a 25 bp cut to 2.25% at Wednesday’s RBNZ meeting. According to economists, this may be the final cut in the cycle.
-
Barclays expects a strong dollar in 2026, supported by a massive AI-capex cycle boosting productivity and growth, high global demand for U.S. technology, and reduced concerns about tariffs. The bank also expects a more stable backdrop for risk assets into 2026.
-
Barclays assumes that Powell is likely to lean toward a cut at the December FOMC meeting. Currently, 6 policymakers lean toward a pause and 5 toward a cut, not counting Powell. He is expected to steer the committee toward easing in December. Governors rarely oppose the Chair, giving him decisive influence.
BREAKING: Germany IFO slightly lower than expected 📌
Economic calendar: delayed US PPI and retail sales report this week 📃
Daily summary: massive selloff in crypto; Fed cut in December 💵
Three market to watch next week (21.11.2025)
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
